Jean-Baptiste Micol

21PUBLICATIONS
167CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 23, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|Apr 24, 2025
CHIP'ing Signal from Noise in Liquid Biopsy.

Elsa Bernard, Jean-Baptiste Micol

|Apr 17, 2025
Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Christophe Willekens, Alexandre Bazinet, Samy Chraibi

|Mar 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

David Fandrei, Jean Pegliasco, Florence Pasquier

Pageof 4

Frequent Collaborators

6 joint publications

Nicolas Duployez

6 joint publications

Arnaud Pagès

6 joint publications

Christian Récher

5 joint publications

Raphael Itzykson